Motor deficits in fibroblast growth factor receptor-3 null mutant mice

M. P. McDonald, K. M. Miller, C. Li, C. Deng, Jacqueline Crawley

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Fibroblast growth factor receptor-3 (FGFR-3) regulates aspects of bone development. Mutations in the FGFR-3 gene (Fgfr3) in humans and mice produce vertebral abnormalities and bone deformities. The present study evaluated the behavioural concomitants of the Fgfr3 - / - mutation. Fgfr3 - / - null mutant mice displayed severe impairments of motor abilities as detected on the rotarod, wire hang and open field tests. Absence of prepulse inhibition of acoustic startle was seen at prepulse levels from 74 to 86 dB. The motor deficits appear to be a direct and predicted consequence of the skeletal kyphosis, scoliosis and long bone overgrowth previously reported in Fgfr3 null mutant mice. The behavioural phenotype displayed by these mutant mice complements their anatomical, physiological and biochemical phenotypes, to complete the characterization of the functional outcome of a single gene mutation. Simple, robust behavioural symptoms, such as poor rotarod performance in Fgfr3 knockout mice, can provide useful surrogate markers to evaluate pharmacological treatments and gene therapies for human genetic diseases.

Original languageEnglish (US)
Pages (from-to)477-486
Number of pages10
JournalBehavioural Pharmacology
Volume12
Issue number6-7
StatePublished - 2001
Externally publishedYes

Fingerprint

Receptor, Fibroblast Growth Factor, Type 3
Genes
Mutation
Phenotype
Bone and Bones
Behavioral Symptoms
Gene Knockout Techniques
Kyphosis
Inborn Genetic Diseases
Aptitude
Bone Development
Medical Genetics
Scoliosis
Acoustics
Knockout Mice
Genetic Therapy
Biomarkers
Pharmacology

Keywords

  • Behavioural phenotyping
  • Fibroblast growth factor
  • Gene mutation
  • Motor behaviour
  • Mouse
  • Neurotrophic factor
  • Prepulse inhibition of acoustic startle

ASJC Scopus subject areas

  • Pharmacology
  • Neuroscience(all)

Cite this

McDonald, M. P., Miller, K. M., Li, C., Deng, C., & Crawley, J. (2001). Motor deficits in fibroblast growth factor receptor-3 null mutant mice. Behavioural Pharmacology, 12(6-7), 477-486.

Motor deficits in fibroblast growth factor receptor-3 null mutant mice. / McDonald, M. P.; Miller, K. M.; Li, C.; Deng, C.; Crawley, Jacqueline.

In: Behavioural Pharmacology, Vol. 12, No. 6-7, 2001, p. 477-486.

Research output: Contribution to journalArticle

McDonald, MP, Miller, KM, Li, C, Deng, C & Crawley, J 2001, 'Motor deficits in fibroblast growth factor receptor-3 null mutant mice', Behavioural Pharmacology, vol. 12, no. 6-7, pp. 477-486.
McDonald, M. P. ; Miller, K. M. ; Li, C. ; Deng, C. ; Crawley, Jacqueline. / Motor deficits in fibroblast growth factor receptor-3 null mutant mice. In: Behavioural Pharmacology. 2001 ; Vol. 12, No. 6-7. pp. 477-486.
@article{f02e5fedfcf84f86b2856bebf311b493,
title = "Motor deficits in fibroblast growth factor receptor-3 null mutant mice",
abstract = "Fibroblast growth factor receptor-3 (FGFR-3) regulates aspects of bone development. Mutations in the FGFR-3 gene (Fgfr3) in humans and mice produce vertebral abnormalities and bone deformities. The present study evaluated the behavioural concomitants of the Fgfr3 - / - mutation. Fgfr3 - / - null mutant mice displayed severe impairments of motor abilities as detected on the rotarod, wire hang and open field tests. Absence of prepulse inhibition of acoustic startle was seen at prepulse levels from 74 to 86 dB. The motor deficits appear to be a direct and predicted consequence of the skeletal kyphosis, scoliosis and long bone overgrowth previously reported in Fgfr3 null mutant mice. The behavioural phenotype displayed by these mutant mice complements their anatomical, physiological and biochemical phenotypes, to complete the characterization of the functional outcome of a single gene mutation. Simple, robust behavioural symptoms, such as poor rotarod performance in Fgfr3 knockout mice, can provide useful surrogate markers to evaluate pharmacological treatments and gene therapies for human genetic diseases.",
keywords = "Behavioural phenotyping, Fibroblast growth factor, Gene mutation, Motor behaviour, Mouse, Neurotrophic factor, Prepulse inhibition of acoustic startle",
author = "McDonald, {M. P.} and Miller, {K. M.} and C. Li and C. Deng and Jacqueline Crawley",
year = "2001",
language = "English (US)",
volume = "12",
pages = "477--486",
journal = "Behavioural Pharmacology",
issn = "0955-8810",
publisher = "Lippincott Williams and Wilkins",
number = "6-7",

}

TY - JOUR

T1 - Motor deficits in fibroblast growth factor receptor-3 null mutant mice

AU - McDonald, M. P.

AU - Miller, K. M.

AU - Li, C.

AU - Deng, C.

AU - Crawley, Jacqueline

PY - 2001

Y1 - 2001

N2 - Fibroblast growth factor receptor-3 (FGFR-3) regulates aspects of bone development. Mutations in the FGFR-3 gene (Fgfr3) in humans and mice produce vertebral abnormalities and bone deformities. The present study evaluated the behavioural concomitants of the Fgfr3 - / - mutation. Fgfr3 - / - null mutant mice displayed severe impairments of motor abilities as detected on the rotarod, wire hang and open field tests. Absence of prepulse inhibition of acoustic startle was seen at prepulse levels from 74 to 86 dB. The motor deficits appear to be a direct and predicted consequence of the skeletal kyphosis, scoliosis and long bone overgrowth previously reported in Fgfr3 null mutant mice. The behavioural phenotype displayed by these mutant mice complements their anatomical, physiological and biochemical phenotypes, to complete the characterization of the functional outcome of a single gene mutation. Simple, robust behavioural symptoms, such as poor rotarod performance in Fgfr3 knockout mice, can provide useful surrogate markers to evaluate pharmacological treatments and gene therapies for human genetic diseases.

AB - Fibroblast growth factor receptor-3 (FGFR-3) regulates aspects of bone development. Mutations in the FGFR-3 gene (Fgfr3) in humans and mice produce vertebral abnormalities and bone deformities. The present study evaluated the behavioural concomitants of the Fgfr3 - / - mutation. Fgfr3 - / - null mutant mice displayed severe impairments of motor abilities as detected on the rotarod, wire hang and open field tests. Absence of prepulse inhibition of acoustic startle was seen at prepulse levels from 74 to 86 dB. The motor deficits appear to be a direct and predicted consequence of the skeletal kyphosis, scoliosis and long bone overgrowth previously reported in Fgfr3 null mutant mice. The behavioural phenotype displayed by these mutant mice complements their anatomical, physiological and biochemical phenotypes, to complete the characterization of the functional outcome of a single gene mutation. Simple, robust behavioural symptoms, such as poor rotarod performance in Fgfr3 knockout mice, can provide useful surrogate markers to evaluate pharmacological treatments and gene therapies for human genetic diseases.

KW - Behavioural phenotyping

KW - Fibroblast growth factor

KW - Gene mutation

KW - Motor behaviour

KW - Mouse

KW - Neurotrophic factor

KW - Prepulse inhibition of acoustic startle

UR - http://www.scopus.com/inward/record.url?scp=0035217751&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035217751&partnerID=8YFLogxK

M3 - Article

C2 - 11742142

AN - SCOPUS:0035217751

VL - 12

SP - 477

EP - 486

JO - Behavioural Pharmacology

JF - Behavioural Pharmacology

SN - 0955-8810

IS - 6-7

ER -